KemPharm, Inc. (ZVRA) Earnings
|
Expand Research on ZVRA
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -43.0% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -6.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/9/26 |
Q325 | N/A | $0.05 | N/A | N/A | $28.05M | N/A | N/A | N/A | ||
| 11/5/25 | Q225 | -$0.01 | -$0.03 | +$0.02 | $26.1M | $26.64M | N/A | ![]() | ![]() | Details | |
| 8/12/25 | Q125 | -$0.06 | $2.19 | -$2.25 | $25.9M | $22.49M | N/A | ![]() | ![]() | Details | |
| 5/13/25 |
Q125 | N/A | -$0.24 | N/A | $20.4M | $16.02M | N/A | N/A | N/A | ||
| 3/11/25 | Q424 | -$0.67 | -$0.40 | -$0.27 | $12M | $8.52M | N/A | ![]() | ![]() | Details | |
| 2/28/25 |
Q424 | N/A | -$0.40 | N/A | N/A | $8.52M | N/A | N/A | N/A | ||
| 11/12/24 | Q324 | -$0.69 | -$0.41 | -$0.28 | $3.69M | $4.87M | N/A | ![]() | ![]() | Details | |
| 8/13/24 | Q224 | -$0.48 | -$0.46 | -$0.02 | $4.4M | $4.41M | N/A | ![]() | ![]() | Details |


